A detailed history of Gradient Investments LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Gradient Investments LLC holds 5 shares of ZTS stock, worth $878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 24 79.17%
Holding current value
$878
Previous $4,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$165.67 - $199.94 $3,147 - $3,798
-19 Reduced 79.17%
5 $0
Q3 2023

Oct 27, 2023

SELL
$167.14 - $192.77 $2,172 - $2,506
-13 Reduced 35.14%
24 $4,000
Q2 2023

Jul 11, 2023

BUY
$160.94 - $186.23 $5,954 - $6,890
37 New
37 $6,000
Q4 2022

Jan 10, 2023

SELL
$131.14 - $157.47 $3,934 - $4,724
-30 Reduced 78.95%
8 $0
Q3 2022

Oct 14, 2022

BUY
$148.29 - $182.55 $4,745 - $5,841
32 Added 533.33%
38 $6,000
Q2 2022

Jul 11, 2022

SELL
$155.97 - $200.09 $8,890 - $11,405
-57 Reduced 90.48%
6 $1,000
Q1 2022

May 26, 2022

SELL
$181.39 - $234.03 $1,813 - $2,340
-10 Reduced 13.7%
63 $12,000
Q4 2021

Jan 12, 2022

BUY
$193.69 - $247.03 $12,977 - $16,551
67 Added 1116.67%
73 $18,000
Q1 2021

Apr 21, 2021

SELL
$144.0 - $169.39 $10,368 - $12,196
-72 Reduced 92.31%
6 $1,000
Q3 2020

Oct 06, 2020

BUY
$137.1 - $165.37 $3,290 - $3,968
24 Added 44.44%
78 $13,000
Q2 2020

Jul 10, 2020

SELL
$111.92 - $142.53 $2,574 - $3,278
-23 Reduced 29.87%
54 $7,000
Q1 2020

Apr 07, 2020

BUY
$92.66 - $144.94 $2,131 - $3,333
23 Added 42.59%
77 $9,000
Q3 2019

Oct 10, 2019

BUY
$112.57 - $128.43 $6,078 - $6,935
54 New
54 $7,000
Q2 2019

Jul 16, 2019

SELL
$97.98 - $114.28 $1,077 - $1,257
-11 Closed
0 $0
Q1 2019

Apr 11, 2019

SELL
$81.56 - $100.67 $12,234 - $15,100
-150 Reduced 93.17%
11 $1,000
Q4 2017

Feb 07, 2018

BUY
$63.24 - $72.8 $10,181 - $11,720
161
161 $12,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.